RSV-A (A2 Strain) Purified Virus
Human Respiratory Syncytial Virus subtype A (A2 Strain) propagated in HEp-2 cells and purified from culture supernatant and cells showing cytopathic effect.
≥ 5 x 109 viral particles per mL of purified RSV-A
≥ 106.0 TCID50 per mL of purified RSV-A
Typical lot size 100-500 vials
For research use only.
APPLICATION FOR USE
- In vitro Infectivity Assay
- Antiviral Studies
- Animal Experimentation
- Nucleic Acid Extraction
- Spiking Studies
- ELISpot Assay
- Virus Neutralization Assay
- Virus Ultrastructural Studies
QUALITY CONTROL TESTING INCLUDES
- Sterility
- TCID50
- Protein Concentration
- Virus Particle Count
SHIPPING AND STORAGE:
This product is shipped frozen on dry ice. Store at -70°C upon receipt. Avoid multiple freeze-thaw cycles as product degradation may result.
RECOMMENDATIONS:
Before use, rapidly thaw frozen vial in a water bath set at 37°C and then store on ice. Use pre-cooled medium/buffer for virus dilution and store on ice before inoculating into cell culture. For future use, aliquot into small amounts and freeze rapidly in a dry ice/alcohol bath and store at -70°C. Do NOT store virus stock at 2–8°C.
SAFE HANDLING RECOMMENDATIONS:
This preparation of RSV is a BIOHAZARDOUS material containing ACTIVE VIRUS and should be handled in accordance with biosafety guidelines defined in the BMBL, NIH-CDC HHS Publication No. (CDC) 21-1112.
REFERENCE ARTICLES
Khan, A., Ng, S., Vandeputte, O., Aljanahi, A., Deyati, A., Cassart, J., Charlebois, R., and Taliaferro, L. (2017). A Multicenter Study To Evaluate the Performance of High-Throughput Sequencing for Virus Detection. mSphere 2, e00307-17. https://doi.org/10.1128/msphere.00307-17
Flynn, J., Durr, E., Swoyer, R., Cejas, P., Horton, M., Galli, J., Cosmi, S., Espeseth, A., Bett, A., and Zhang, L. (2016). Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein. PLOS ONE 11, e0164789. https://doi.org/10.1371/journal.pone.0164789
Saravia, J., You, D., Shrestha, B., Jaligama, S., Siefker, D., Lee, G., Harding, J., Jones, T., Rovnaghi, C., and Bagga, B. et al. (2015). Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33. PLOS Pathogens 11, e1005217. https://doi.org/10.1371/journal.ppat.1005217
You, D., Siefker, D., Shrestha, B., Saravia, J., and Cormier, S. (2015). Building a better neonatal mouse model to understand infant respiratory syncytial virus disease. Respiratory Research 16:91. https://doi.org/10.1186/s12931-015-0244-0
Cormier, S., Shrestha, B., Saravia, J., Lee, G., Shen, L., DeVincenzo, J., Kim, Y., and You, D. (2014). Limited Type I Interferons and Plasmacytoid Dendritic Cells during Neonatal Respiratory Syncytial Virus Infection Permit Immunopathogenesis upon Reinfection. Journal Of Virology 88, 9350-9360. https://doi.org/10.1128/jvi.00818-14
Huang, H., Saravia, J., You, D., Shaw, A., and Cormier, S. (2014). Impaired gamma delta T cell-derived IL-17A and inflammasome activation during early respiratory syncytial virus infection in infants. Immunology And Cell Biology 93, 126-135. https://doi.org/10.1038/icb.2014.79
- New Product
- Available as Custom Product-Discontinued
- Limited Quantities Remaining-Discontinued
- Call For Availability
- Biohazard Category A
- Biohazard Category B
-
10-150-000SIV (mac251 Strain) Purified Viral Lysate1.0 mg$12,000
-
10-171-100HHV-6B (Z-29 Strain) Purified Virus50 µg$2,000
Biohazard Category B
-
10-171-000HHV-6B (Z-29 Strain) Purified Virus0.5 mg$22,000
Biohazard Category B
-
10-103-100HCMV (AD169 Strain) Purified Virus100 µg$1,500
Biohazard Category B
-
10-103-000HCMV (AD169 Strain) Purified Virus1.0 mg$12,000
Biohazard Category B
-
10-188-000HIV-1 (MN Strain) Purified Virus1.0 mg
Biohazard Category A
-
10-291-000Reovirus-1 (Lang Strain) Purified Virus1.0 mg$15,000
Biohazard Category B
-
10-254-000Vaccinia (WR Strain) Purified Virus1.0 mg
Biohazard Category B
-
10-252-000Vaccinia (Lister Strain) Purified Virus1.0 mg
Biohazard Category B
-
10-223-100SRV-5 Purified Virus100 µg
Biohazard Category B
-
10-223-000SRV-5 Purified Virus1.0 mg
Biohazard Category B
-
10-218-000SRV-2 Purified Virus1.0 mg
Biohazard Category B
-
10-152-000SRV-1 (Macaque Strain) Purified Virus1.0 mg
Biohazard Category B
-
10-152-100SRV-1 (Macaque Strain) Purified Virus100 µg
Biohazard Category B
-
10-149-000SIV (mac251 Strain) Purified Virus1.0 mg
Biohazard Category B
-
10-149-100SIV (mac251 Strain) Purified Virus100 µg
Biohazard Category B
-
10-247-100RSV-A (A2 Strain) Purified Virus100 µg
Biohazard Category B
-
10-288-000PCV2b Purified Virus1.0 mL
Biohazard Category B
-
10-220-500Human Influenza B/Lee/40 Purified Virus0.5 mg
Biohazard Category B
-
10-210-500Human Influenza A/PR/8/34 (H1N1) Purified Virus0.5 mg
Biohazard Category B
-
10-287-500Human Influenza A/New Caledonia/20/99 (H1N1) Purified Virus0.5 mg
Biohazard Category B
-
10-281-500Human Influenza A/Mexico/4108/2009 (H1N1) Purified Virus (Swine-Origin)0.5 mg
Biohazard Category B
-
10-201-500Human Influenza A/Hong Kong/8/68 (H3N2) Purified Virus0.5 mg
Biohazard Category B
-
10-280-500Human Influenza A/California/4/2009 (H1N1) Purified Virus (Swine-Origin)0.5 mg
Biohazard Category B
-
10-259-000Human Influenza A/2/Japan/305/57 (H2N2) Purified Virus1.0 mg
Biohazard Category B
-
10-112-000HTLV-I (MT-2 Strain) Purified Virus1.0 mg
Biohazard Category B
-
10-112-100HTLV-I (MT-2 Strain) Purified Virus100 µg
Biohazard Category B
-
10-110-000HSV-1 (MacIntyre Strain) Purified Virus1.0 mg
Biohazard Category B
-
10-127-000HIV-2 (NIH-Z Strain) Purified Virus1.0 mg
Biohazard Category A
-
10-118-000HIV-1 (IIIB Strain) Purified Virus1.0 mg
Biohazard Category A
-
10-118-100HIV-1 (IIIB Strain) Purified Virus100 µg
Biohazard Category A
-
10-250-000FeLV (Thielen Strain) Purified Virus1.0 mg
Biohazard Category B
-
10-115-000EBV (B95-8 Strain) Purified Virus1.0 mg
Biohazard Category B
-
10-115-100EBV (B95-8 Strain) Purified Virus100 µg
Biohazard Category B
-
10-198-000Human Adenovirus-5 Purified Virus1.0 mL
Biohazard Category B